BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 33729021)

  • 1. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
    Cares-Marambio K; Montenegro-Jiménez Y; Torres-Castro R; Vera-Uribe R; Torralba Y; Alsina-Restoy X; Vasconcello-Castillo L; Vilaró J
    Chron Respir Dis; 2021; 18():14799731211002240. PubMed ID: 33729021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Post-COVID-19 Cough One Year After SARS-CoV-2 Infection: A Multicenter Study.
    Fernández-de-Las-Peñas C; Guijarro C; Plaza-Canteli S; Hernández-Barrera V; Torres-Macho J
    Lung; 2021 Jun; 199(3):249-253. PubMed ID: 33993321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study.
    Xiong Q; Xu M; Li J; Liu Y; Zhang J; Xu Y; Dong W
    Clin Microbiol Infect; 2021 Jan; 27(1):89-95. PubMed ID: 32979574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
    Alkodaymi MS; Omrani OA; Fawzy NA; Shaar BA; Almamlouk R; Riaz M; Obeidat M; Obeidat Y; Gerberi D; Taha RM; Kashour Z; Kashour T; Berbari EF; Alkattan K; Tleyjeh IM
    Clin Microbiol Infect; 2022 May; 28(5):657-666. PubMed ID: 35124265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatigue and Dyspnoea as Main Persistent Post-COVID-19 Symptoms in Previously Hospitalized Patients: Related Functional Limitations and Disability.
    Fernández-de-Las-Peñas C; Palacios-Ceña D; Gómez-Mayordomo V; Palacios-Ceña M; Rodríguez-Jiménez J; de-la-Llave-Rincón AI; Velasco-Arribas M; Fuensalida-Novo S; Ambite-Quesada S; Guijarro C; Cuadrado ML; Florencio LL; Arias-Navalón JA; Ortega-Santiago R; Elvira-Martínez CM; Molina-Trigueros LJ; Torres-Macho J; Sebastián-Viana T; Canto-Diez MG; Cigarán-Méndez M; Hernández-Barrera V; Arendt-Nielsen L
    Respiration; 2022; 101(2):132-141. PubMed ID: 34569550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent symptoms among post-COVID-19 survivors: A systematic review and meta-analysis.
    Rochmawati E; Iskandar AC; Kamilah F
    J Clin Nurs; 2024 Jan; 33(1):29-39. PubMed ID: 36426658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-Discharge Symptoms among Hospitalized COVID-19 Patients in Nigeria: A Single-Center Study.
    Ogoina D; James HI; Ogoinja SZ
    Am J Trop Med Hyg; 2021 Jul; 105(3):731-736. PubMed ID: 34270448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea.
    Cortés-Telles A; López-Romero S; Figueroa-Hurtado E; Pou-Aguilar YN; Wong AW; Milne KM; Ryerson CJ; Guenette JA
    Respir Physiol Neurobiol; 2021 Jun; 288():103644. PubMed ID: 33647535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity.
    Townsend L; Dowds J; O'Brien K; Sheill G; Dyer AH; O'Kelly B; Hynes JP; Mooney A; Dunne J; Ni Cheallaigh C; O'Farrelly C; Bourke NM; Conlon N; Martin-Loeches I; Bergin C; Nadarajan P; Bannan C
    Ann Am Thorac Soc; 2021 Jun; 18(6):997-1003. PubMed ID: 33413026
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long lasting symptoms of dyspnea, cough and fatigue after COVID-19 - narrative review of epidemiological studies].
    Marciniak E; Górniak A; Hanke W
    Med Pr; 2021 Dec; 72(6):711-720. PubMed ID: 34850782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 disease severity to predict persistent symptoms: a systematic review and meta-analysis.
    Dirican E; Bal T
    Prim Health Care Res Dev; 2022 Nov; 23():e69. PubMed ID: 36352492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study.
    Chudzik M; Babicki M; Kapusta J; Kałuzińska-Kołat Ż; Kołat D; Jankowski P; Mastalerz-Migas A
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
    Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
    Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up.
    Tleyjeh IM; Saddik B; AlSwaidan N; AlAnazi A; Ramakrishnan RK; Alhazmi D; Aloufi A; AlSumait F; Berbari E; Halwani R
    PLoS One; 2021; 16(12):e0260568. PubMed ID: 34874962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae.
    Daher A; Balfanz P; Cornelissen C; Müller A; Bergs I; Marx N; Müller-Wieland D; Hartmann B; Dreher M; Müller T
    Respir Med; 2020; 174():106197. PubMed ID: 33120193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.
    Taquet M; Dercon Q; Luciano S; Geddes JR; Husain M; Harrison PJ
    PLoS Med; 2021 Sep; 18(9):e1003773. PubMed ID: 34582441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis.
    Lee JH; Yim JJ; Park J
    Respir Res; 2022 Sep; 23(1):233. PubMed ID: 36068582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for post-acute sequelae of COVID-19 in hospitalized patients: An observational study based on a survey in a tertiary care center in Türkiye.
    Yıldız Y; Öztürk Şahin B; Demir MC; Demir Ş; Çiftci B; Köktürk N; Ulukavak Çiftçi T; Yurdakul AS; Yılmaz Demirci N; Aydoğdu M; Dizbay M; Oğuzülgen İK
    Tuberk Toraks; 2023 Sep; 71(3):261-272. PubMed ID: 37740629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived severe acute respiratory syndrome coronavirus 2 infection: a systematic review and meta-analysis.
    Fernández-de-Las-Peñas C; Navarro-Santana M; Plaza-Manzano G; Palacios-Ceña D; Arendt-Nielsen L
    Pain; 2022 Jul; 163(7):1220-1231. PubMed ID: 34561390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.